Psychoactive cannabinoids and membrane signaling

Human Psychopharmacology

Volumn 15, Issue 7, 2000, Pages 535-549

  Nahas, Gabriel G ^a   Harvey, David J ^b   Sutin, Kenneth M ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Cannabinoid; Deregulation; GPCR receptor; Membrane lipid bilayer; THC

Indexed keywords

CALNEXIN; CANNABINOID; CANNABINOL; ETHANOLAMINE; GUANINE NUCLEOTIDE BINDING PROTEIN; MEMBRANE RECEPTOR; PHOSPHOLIPASE; TETRAHYDROCANNABINOL;

ALLOSTERISM; ARTICLE; CELL FUNCTION; DEREGULATION; ENZYME ACTIVATION; EXTRACELLULAR SPACE; LIGAND BINDING; LIPID BILAYER; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

EID: 0033693267     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/1099-1077(200010)15:7<535::AID-HUP229>3.0.CO;2-7     Document Type: Article

References (99)

1. The cloned rat hydrolytic enzyme responsible for the breakdown of anandamide also catalyzes its formation via the condensation of arachidonic acid and ethanolamine
2. Receptor-mediated activation of phospholipase A2 via GTP-binding proteins: Arachidonic acid and its metabolites as second messengers
3. The interaction of hashish compounds with planar lipid bilayer membranes
4. Influence of neurotransmitter uptake in rat brain synaptosomes
5. Arachiclonate metabolite signaling
6. Delta-9-THC increases brain prostaglandins in the rat
7. Cannabinoid receptor-regulated cyclic AMP accumulation in the rat striatum
8. Biosynthesis uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes
9. Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells
10. Cannabinoids and neurotransmitter receptors
11. Cannabinoids, neurotransmitter receptors and brain membranes
12. Interaction of ambient temperature with the effects of delta-9-THC on brain catecholamine synthesis and plasma corticosterone levels
13. The effects of cannabinoids on body temperature and brain catecholamine synthesis
14. Non-classical and endogenous cannabinoids: Effects on the ordering of brain membranes
15. Cannabidiol interaction with delta-9-tetrahydrocannabinol
16. The effects of delta-9-tetra-hydrocannabinol alone and in combination with cannabidiol on fixed-interval performance in rhesus monkeys
17. Prostaglandins and cannabis IX. Stimulation of PGE-2 synthesis in human lung fibroblasts by delta-1-THC
18. Prostaglandins and cannabis XII. The effect of cannabinoid structure on the synthesis of prostaglandins by human lung fibroblasts
19. In vitro models of cannabinoid-induced psychoactivity
20. Prostaglandins and cannabis-XVI: Antagonism of delta-1-tetrahydrocannabinol action by its metabolites
21. Antagonism to the actions of platelet activating factor by a nonpsychoactive cannabinoid
22. Relationships between eicosanoids and cannabinoids. Are eicosanoids cannabimimetic agents?
23. Cannabis and endogenous cannabinoid systems
24. Effects of moderate and high doses of marihuana on thermal pain: A sensory decision theory analysis
25. Cannabidiol-antiepileptic drug comparisons and interactions in experimentally induced seizures in rats
26. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
27. Influence of cannabidiol on delta-9-tetrahydrocannabinol effects
28. Cannabinoid ligand-receptor signaling in the mouse uterus
29. Soft matter
30. Determination and characterization of a cannabinoid receptor in rat brain
31. Isolation and structure of a brain constituent that binds to the cannabinoid receptor
32. Biosynthesis of anandamide and related acylethanolamides in mouse J774 macrophages and N18 neuroblastoma cells
33. Potential biosynthetic connections between the two cannabimimetic eicosanoids, anandamide and 2-arachidonoyl-glycerol, in mouse neuroblastoma cells
34. Cannabinoids and the cholinergic system
35. Central nervous system actions of some synthetic tetrahydrocannabinol derivatives
36. Towards a cannabinoid hypothesis of schizophrenia: Cognitive impairments due to dysregulation of the endogenous cannabinoid system
37. Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide
38. Cannabinoid receptors and their endogenous agonists
39. Cannabinoid agonists stimulate both receptor and non-receptor mediated signal transduction pathways in cells transfected and expressing cannabinoid receptor clones
40. Delta 9-tetrahydrocannabinol inhibition of tumor necrosis factor-alpha: Suppression of post-translational events
41. Inhibition of hippocampal acetylcholine release by cannabinoids: Reversal by SR 141716A
42. The physicochemical mode of action of THC on cell membranes
43. Dual effects of anandamide on NMDA receptor-mediated responses and neurotransmission
44. Multiple enzymatic activities of the human systolic 85-kDa phospholipase a2: Hydrolytic reactions and acyl transfer to glycerol
45. Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor
46. Metabolism and pharmacokinetics of the cannabinoids
47. Changes in human spermatoza associated with high dose marihuana smoking
48. Cannabinoid receptor localization in brain
49. Effect of cannabinoids on neurotransmitter uptake, ATPase activity and morphology of mouse brain synaptosomes
50. Biochemistry and pharmacology of arachidonylethanolamide, a putative endogenous cannabinoid
51. Interactions of delta-9-THC and CBD
52. Cannabinoid compounds and signal transduction mechanisms
53. Molecular motion in spin-labelled phospholipids and membranes
54. Cannabinoid modulated phospholipase activities by mouse brain subcellular fractions
55. Long-range order in biomembranes
56. Effects of delta-9-THC on the synaptosomal uptake of 3-H-tryptophan and 3-H-choline
57. Cannabidiol interferes with the effect of delta-9-tetrahydrocannabinol in the rat
58. Comparison of experimental binding data and theoretical models in proteins containing subunits
59. Reversible hydrolysis and synthesis of anandamide demonstrated by recombinant rat fatty-acid amide hydrolase
60. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice
61. The partitioning of delta-1-THC into erythrocyte membranes in vivo and its effect on membrane fluidity
62. Localization of cannabinoid receptors and nonsaturable high-density cannabinoid binding sites in peripheral tissues of the rat: Implications for receptor-mediated immune modulation by cannabinoids
63. The role of cell membranes in cannabinoid activity
64. The molecular features of membrane perturbation by anesthetic steroids: A study using differential scanning calorimetry, small angle X-ray diffraction and solid state 2-H NMR
65. Structure of a cannabinoid receptor and functional expression of the cloned cDNA
66. In discussion of Weissman A., 1981 on the definition of cannabinoids
67. Cannabinoids and membrane-bound enzymes
68. Allosteric proteins and cellular control systems
69. Molecular characterization of a peripheral receptor for cannabinoids
70. Effects and interactions of cannabinoids on the isolated heart
71. From human to molecule
72. Modulation of interleukin 2 activity by delta 9-tetrahydrocannabinol after stimulation with concanavalin A, phytohemagglutinin, or anti-CD3 antibody
73. The preimplantation mouse embryo is a target for cannabinoid ligand-receptor signaling
74. The general pharmacology of cannabinoids
75. Pharmacology of orally-administered delta-9-tetrahydrocannabinol
76. Antagonism of marihuana effects by indomethacin in humans
77. Pharmacological, physiological and clinical implications of the discovery of cannabinoid receptors: An overview
78. An endogenous cannabinoid as an endothelium-derived vasorelaxant
79. Effects of delta-9-THC on prostaglandin formation in the brain
80. Delta-9-THC increases arachidonic acid levels in guinea pig cerebral cortex slices
81. Delta-9-THC inhibits arachidonic acid acylation of phospholipids and triacyglycerols in guinea pig cerebral cortex slices
82. Regulation of membrane enzymes by lipids
83. Occurrence and postmortem generation of anandamide and other long-chain N-acylethanolamines in mammalian brain
84. Anandamide (arachidonylethanolamide), a brain cannabinoid receptor agonist, reduces fertilizing capacity in sea urchins by inhibiting the acrosome reaction
85. The fluid mosaic model of the structure of cell membranes
86. Differential impairments of selective attention due to frequency and duration of cannabis use
87. A second endogenous cannabinoid that modulates long-term potentiation
88. Transacylase-mediated and phosphodiesterase-mediated synthesis of N-arachidonoylethanolamine, an endogenous cannabinoid-receptor ligand, in rat brain microsomes
89. Enzymatic synthesis of anadamide, an endogenous cannabinoid receptor ligand, through N-acylphosphatidylethanolamine pathway in testis: Involvement of Ca(2+)-dependent transacylase and phosphodiesterase activities
90. Correlation between the psychotropic potency of cannabis and their effect on the 1-H-NMR spectra of model membranes
91. The effect of two inhalation anaesthetics on the order of spin-labelled phospholipic vesicles
92. Constituents of Cannabis sativa L. XVII, A review of the natural constituents
93. Enzymes for anadamide biosynthesis and metabolism
94. Modulation of rat brain opioid receptors by cannabinoids
95. Effects of chronic ethanol administration on the composition of membrane lipids in the mouse
96. Characterization of CoA independent transacylase activity in U937 cells
97. Characteristics of the stimulus produced by the mixture of cannabidiol with delta-9-tetrahydrocannabinol
98. Dimethylheptyl-THC-11-oic acid: A nonpsychoactive antiinflammatory agent with a cannabinoid template structure